BIOGNOSYS Trademark

Trademark Overview


On Thursday, March 31, 2016, a trademark application was filed for BIOGNOSYS with the United States Patent and Trademark Office. The USPTO has given the BIOGNOSYS trademark a serial number of 86960274. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 26, 2018. The BIOGNOSYS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

(Based on Use in Commerce) Charitable services, namely, providing medical equipment and services to underserved communities; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical testing for diagnostic or treatment purposes in the field of autism spectrum disorders (ASD), Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Medical testing of urine, blood, hair follicles and breath; Medical diagnostic testing, monitoring and reporting services; Performing diagnosis of diseases; Providing medical information; Providing medical information in the field of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing medical information to patients and medical professionals in the form of reports in the field of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ...
biognosys

General Information


Serial Number86960274
Word MarkBIOGNOSYS
Filing DateThursday, March 31, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements


Goods and Services(Based on Use in Commerce) Charitable services, namely, providing medical equipment and services to underserved communities; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical testing for diagnostic or treatment purposes in the field of autism spectrum disorders (ASD), Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Medical testing of urine, blood, hair follicles and breath; Medical diagnostic testing, monitoring and reporting services; Performing diagnosis of diseases; Providing medical information; Providing medical information in the field of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing medical information to patients and medical professionals in the form of reports in the field of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing personalized healthcare and medical information in the nature of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Consulting services in the fields of diagnostic medical testing and nutrition; Medical diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Medical screening; Mental health screening services; Providing medical information, consultancy and advisory services; (Based on Intent to Use) Providing an on-line, patient-initiated, patient-authorized, fee-for-service, medical profile and medical record analysis service designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Providing a website featuring information in the field of the diagnosis and treatment of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing an internet website featuring news and information relating to diagnosis and treatment of autism

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 5, 2016
Primary Code044
First Use Anywhere DateWednesday, August 1, 2007
First Use In Commerce DateWednesday, August 1, 2007

Trademark Owner History


Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressNew York, NY 10025

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressNew York, NY 10025

Trademark Events


Event DateEvent Description
Monday, March 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 22, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, July 9, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, March 28, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 24, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, January 24, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 24, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, January 24, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, January 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 21, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 21, 2016NON-FINAL ACTION E-MAILED
Thursday, July 21, 2016NON-FINAL ACTION WRITTEN
Thursday, July 14, 2016ASSIGNED TO EXAMINER
Tuesday, April 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 4, 2016NEW APPLICATION ENTERED IN TRAM